Mixed Antagonist of Serotonin for Claudication Optimal Therapy

Summary

To investigate in patients suffering from intermittent claudication due to Fontaine stage II PAD whether a 24-week treatment by SL650472 OD on top of clopidogrel may result in an improvement of walking capacity, by comparing three doses of SL650472 to placebo, and to calibrate such effect versus cilostazol

Timeline

Start

2006-02

Primary completion

2007-12

Completion

2007-12

Drugs

Indications